GENEPOC
GenePOC Inc. is a privately owned company, member of Debiopharm Group, that develops accurate and cost-effective molecular solutions to detect pathogen genes. GenePOC has developed a simple and stand-alone system for the prevention and early detection of infectious diseases based on a unique microfluidic technology.
GENEPOC
Industry:
Health Diagnostics Pharmaceutical
Address:
Quebec, Quebec, Canada
Country:
Canada
Website Url:
http://www.genepoc-diagnostics.com
Status:
Active
Contact:
+ 1-418-650-3535
Technology used in webpage:
Google Maps Google Google Maps API Google Cloud WP Engine Google Maps For Work ENom DNS
Similar Organizations
Diversitec
Diversitec is a privately held company.
Isuru
Isuru, Inc. is a privately owned corporation.
NuBiyota
NuBiyota LLC is a privately held company.
Official Site Inspections
http://www.genepoc-diagnostics.com
- Host name: 40.108.185.35.bc.googleusercontent.com
- IP address: 35.185.108.40
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "GenePOC"
Meridian Bioscience Announces Agreement to Acquire Business of …
Apr 30, 2019 Founded in 2007, GenePOC has approximately 100 employees and generated total revenues of less than $1 million in calendar 2018. Meridian has agreed to make a cash …See details»
GenePOC - Crunchbase Company Profile & Funding
GenePOC Inc. is a privately owned company, member of Debiopharm Group, that develops accurate and cost-effective molecular solutions to detect pathogen …See details»
GenePOC, a subsidiary of Debiopharm Group, reaches an …
GenePOC’s (Canadian affiliate of Debiopharm) molecular diagnostics business portfolio. This decision was made in response to the need to identify a partner with a solid commercialization …See details»
GenePOC Inc. - rapidmicrobiology
Jun 23, 2018 GenePOC Inc. Address Québec Canada. Contact Details +1 (418) 650-3535 . Develops cost-effective and rapid molecular devices to detect pathogen genes at Point-of …See details»
GenePOC - Practical Patient Care
GenePOC develops diagnostic devices and assays for the prevention and detection of infectious diseases. Its new revogene instrument – a fully automated, stand-alone diagnostic system – …See details»
Genepoc Inc. - BioCentury Company Profiles - BCIQ
Mar 10, 2017 Genepoc Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Meridian Bioscience to buy GenePOC in $120m deal
Diagnostic testing solutions firm Meridian Bioscience has signed a definitive agreement to acquire Canadian molecular diagnostics maker GenePOC in a deal valued at $120m. GenePOC, which was founded in 2007, is a subsidiary of …See details»
GenePOC, a Subsidiary of Debiopharm Group, Reaches an …
Apr 30, 2019 About GenePOC. Founded in 2007 by Dr. Michel Bergeron, GenePOC is a company that specializes in the development of diagnostic devices which enable the …See details»
Meridian Bioscience Announces Closing of Transaction to Acquire ...
CINCINNATI, June 03, 2019 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today …See details»
Meridian Bioscience Buys GenePOC - rapidmicrobiology
Meridian Bioscience, Inc. has entered into a definitive agreement to acquire the business of GenePOC Inc., a Quebec City, Quebec, Canada based provider of molecular diagnostic …See details»
GenePOC® launches its GenePOC® CDiff test in Canada
Oct 23, 2018 GenePOC announces the Health Canada approval and launch of its molecular diagnostic test for the detection of Clostridium difficile in Canada Québec, Canada – October …See details»
GenePOC, a subsidiary of Debiopharm, reaches an agreement with …
Apr 30, 2019 Lausanne, Switzerland – 30th of April, 2019 – Debiopharm (www.debiopharm.com), announced today having reached an agreement with Meridian …See details»
Debiopharm invests double digit millions in the Canadian startup ...
Aug 30, 2016 GenePOC, which has just received CE marking for its first bacteriological test, will start commercialization in Europe this autumn, and Debiopharm will set up a future production …See details»
The GenePOC Platform, a Rational Solution for Extreme Point-of
Feb 19, 2016 GenePOC Inc. (Québec City, QC, Canada) was established in 2007 to develop and industrialize a microfluidic centripetal platform enabling a rtPCR or RT-rtPCR molecular …See details»
Debiopharm Diagnostics leads investment round in GenePOC with …
Jan 13, 2015 GenePOC is a Canadian company which has developed a rapid, innovative, low cost MDx platform for the detection of infectious diseases. Lausanne, Switzerland – January …See details»
GenePOC, une société du groupe Debiopharm, signe un accord …
COMMUNIQUE DE PRESSE GenePOC, une société du groupe Debiopharm, signe un accord avec Meridian Bioscience pour l’acquisition de ses activités de diagnostic moléculaire …See details»
(PDF) The GenePOC Platform, a Rational Solution for
May 24, 2016 The GenePOC CDiff ® is a qualitative point-of-care test that utilizes automated sample preparation and RT-PCR to detect tcdB in liquid diarrhea stool samples for the …See details»
GenePOC, a subsidiary of Debiopharm group, reaches an …
Debiopharm, announced having reached an agreement with Meridian Bioscience. for Meridian to acquire GenePOC’s (Canadian affiliate of Debiopharm) molecular diagnostics business …See details»
Debiopharm invests double digit millions in the canadian startup ...
GenePOC, which has just received CE marking for its first bacteriological test, will start commercialization in Europe this autumn, and Debiopharm will set up a future production line …See details»
GenePOC obtains FDA clearance for its GenePOC™ strep A test in …
Member of the Debiopharm, announces its third test to be cleared by the FDA, the GenePOC strep A assay, to be used with the revogeneâ„¢ device. About A Streptococcus (GAS) infection …See details»